期刊
MOLECULAR DIVERSITY
卷 26, 期 1, 页码 309-329出版社
SPRINGER
DOI: 10.1007/s11030-021-10220-8
关键词
Papain-like protease (PLpro); SARS-CoV2 novel coronavirus; Fungal metabolites; Molecular dynamics simulation; GRL0617
类别
资金
- Department of Microbiology and Biotechnology, School of Sciences, Gujarat University
- UGC [F.30-521/2020(BSR)]
- DST-FIST
The non-structural protein (nsp)-3 of SARS-CoV2, also known as papain-like protease (PLpro), is considered as an essential target protein for inhibiting the replication of the virus. Studies have identified GRL0617 and Fonsecin as potent inhibitors for PLpro, which may help in boosting the immune response.
The non-structural protein (nsp)-3 of SARS-CoV2 coronavirus is sought to be an essential target protein which is also named as papain-like protease (PLpro). This protease cleaves the viral polyprotein, but importantly in human host it also removes ubiquitin-like interferon-stimulated gene 15 protein (ISG15) from interferon responsive factor 3 (IRF3) protein which ultimately downregulates the production of type I interferon leading to weakening of immune response. GRL0617 is the most potent known inhibitor for PLpro that was initially developed for SARS outbreak of 2003. The PLpro of SARS-CoV and CoV2 share 83% sequence identity but interestingly have several identical conserved amino acids that suggests GRL0617 to be an effective inhibitor for PLpro of SARS-CoV2. GRL0617 is a naphthalene-based molecule and interacts with Tyr268 of SARS-CoV2-PLpro (and Tyr269 of SARS-CoV-PLpro). To identify PLpro inhibitors, we prepared a library of secondary metabolites from fungi with aromatic nature and docked them with PLpro of SARS-CoV and SARS-CoV2. We found six hits which interacts with Tyr268 of SARS-CoV2-PLpro (and Tyr269 of SARS-CoV-PLpro). More surprisingly the top hit, Fonsecin, has naphthalene moiety in its structure, which recruits Tyr268 of SARS-CoV-2-PLpro (and Tyr269 of SARS-CoVPLpro) and has binding energy at par with control (GRL0617). Molecular dynamics (MD) simulation showed Fonsecin to interact with Tyr268 of SARS-CoV2-PLpro more efficiently than control (GRL0617) and interacting with a greater number of amino acids in the binding cleft of PLpro. [GRAPHICS] .
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据